Masato Kashimura
Taisho Pharmaceutical Co.
31 Papers
131 Citations
Masato Kashimura is an academic researcher from Taisho Pharmaceutical Co.. The author has contributed to research in topics: Formic acid & Derivative (chemistry). The author has an hindex of 7, co-authored 31 publications. Previous affiliations of Masato Kashimura include Josai University.
Chat about Author
Papers
Patent
2'-position modified compound of erythromycin or its derivative
Toshifumi Asaka,Yoko Misawa,Masato Kashimura,Shigeo Morimoto,Yoshiaki Watanabe,Katsuo Hatayama +5 more
- 08 Oct 1991
TL;DR: Erythromycins showing an extremely relieved bitterness at administration and an improved absorbability in vivo when orally administered are provided in this paper, where a compound having a group represented by the following formula: --O--CO--O--(CH.sub.m --O].sub.n --R (wherein R represents an alkyl group having from 1 to 12 carbon atoms, m represents an integer of from 2 to 4, and n represents a integer of between 1 to 7) at the 2'-position of erythromycin or a salt thereof.
15
Patent
Erythromycin a 11, 12-carbamate derivatives
Toshifumi Asaka,Masato Kashimura,Akiko Matsuura,Tomohiro Sugimoto,Tetsuya Tanikawa,Takaaki Ishii +5 more
- 28 Oct 1998
TL;DR: An erythromycin derivative represented by formula (I) wherein n is an integer of 1 to 7, R1 is a hydrogen atom or an alkyl group, R2 is a quinolyl group or a naphthyl group as discussed by the authors, R3 is a cinnamyl group, or R?4 and R?5? together form an oxo group.
14
Structure-activity relationship study of 6-O-Methylerythromycin 9-O-substituted oxime derivatives
Yutaka Kawashima,Yuki Yamada,Toshifumi Asaka,Yoko Misawa,Masato Kashimura,Sigeo Morimoto,Takeo Ono,Takatoshi Nagate,Katsuo Hatayama,Shuichi Hirono,Ikuo Moriguchi +10 more
TL;DR: In QSARs of 6-O-methyl EM-A 9- O-substituted oxime derivatives, the difference of the contribution of log P to the antibacterial activity between EM-resistant and susceptible strains was clearly recognized.
12